rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Plethico Pharmaceuticals Ltd.: Experts' corner
532739 PLETHICO Group (B) BSE data
Back to Company Page
Management speaks
Sanjay Pai
Sanjay Pai
Chief Financial Officer
Plethico Pharmaceuticals Ltd.
February 23, 2011, 12:02 pm
Why should an investor buy your company's stock?

We believe we are the pioneers in the sports nutraceuticals industry in India

Established Presence in Key Markets

  • Present in over 60 countries globally (US, Europe, CIS, Latin America, S.E. Asia, Middle East , India and Africa)

Diversified Product Portfolio

  • Presence in a wide range of segments such as sports nutrition, food supplements, mouth fresheners, cough and cold medications, lifestyle diseases etc
  • 500-plus formulations and a portfolio of over 200 brands

Strong Manufacturing Base

  • Three manufacturing facilities in India which are CGMP compliant. Kalaria facility UK MHRA accredited. Indian facilities certified by World Health Organization
  • One US CGMP complaint manufacturing facility in the US
  • Manufacturing facility in the UAE enjoying a 50-year tax holiday expected to commence operations by the end of 2010

Large Distribution Network and High Recall Brands

  • Access to CIS markets via stakes in pharmacy chain of Tricon and distribution company Rezlov
  • Channel Natrol brand into India markets through JV with Molekule
  • Portfolio of well recognized brands, such as Prolab, MRI, Travisil Laci Le Beau and ShenMin amongst others

Senior management team of COO, CFO and President have been with the company for over 15 years each

Robust financials

What events do you expect in your industry sector over the next few months? Are these hurdles or catalysts?
  • Growth in the global neutraceuticals industry is projected to be buoyed by rising sales in traditional markets like the US and Europe and in emerging markets like China and India.
  • Consolidation in the industry is a given. Companies that will survive the ongoing consolidation in the dietary supplement industry will be forced to become more global.
  • Key factors that determine the survival of a neutraceutical company are not only its global nature but also economies of scale and scope.
  • A nutraceutical company's ability to protect its products using intellectual property will be a growing measure of its competitiveness and survivability in the future.
  • One future growth trend for nutraceutical companies is the formation of international joint ventures to harness the best country sources of supply
What growth initiatives has your company planned?
  • Expand distribution capabilities in the CIS, Europe and South-East Asia
  • Leverage strong distribution network to introduce herbal products in the US
  • Streamline the product portfolio, integrate production facilities and decrease outsourced production
  • Become one of the leading sports nutrition and dietary supplements company globally
  • Establish the presence of nutraceutical products in Plethico’s existing markets
  • Establish the presence of herbal and allopathic products in regulated markets
  • Become a well integrated, leading global nutraceutical company
  • Strengthen the balance sheet and improve credit cycle terms
Who is your competition? What differentiates you from them?

Our principal competition in the health food store distribution channel (primarily in the US) comes from a limited number of large nationally known manufacturers and many smaller manufacturers of dietary supplements.

In the mass-market distribution channel, the principal competition comes from broad line manufacturers, major private label manufacturers and other companies.

In addition, several large pharmaceutical companies compete with the nutritional supplement companies. Competition from such companies is strong because they have greater financial and other resources available to them and possess manufacturing, distribution and marketing capabilities far greater than Plethico’s. 

Plethico also faces strong competition in both the health food store and mass-market distribution channels from private label dietary supplements offered by health and natural food store chains, drugstore chains, mass merchandisers and supermarket chains.

 

Differentiators :


Largely, we play niche -- for example, we are leaders in smaller niche vitamin categories like Melatonin, 5HTP, Carb Intercept. In sports nutrition, we have created altogether new categories called NO2.

How do you see your company performing over the next financial year?

We will be able to answer this question after we announce the full year results for FY 2010.